O-GlcNAcylation links ChREBP and FXR to glucose-sensing

Frontiers in Endocrinology

Volumn 5, Issue DEC, 2014, Pages

  Benhamed, Fadila ^a,b   Filhoulaud, Gaelle ^a,b   Caron, Sandrine ^c,d,e,f   Lefebvre, Philippe ^c,d,e,f   Staels, Bart ^c,d,e,f   Postic, Catherine ^a,b  

^a INSTITUT COCHIN   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c France IPL F 59000 Lille France   (France)

^d European Genomic Institute for Diabetes ^*  (France)

^e UNIV LILLE   (France)

^f INSTITUT PASTEUR DE LILLE   (France)

Author keywords

ChREBP; FXR; Glucose sensing; Liver metabolism; O GlcNAcylation

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR; CARBOHYDRATE RESPONSIVE ELEMENT BINDING PROTEIN; CELL NUCLEUS RECEPTOR; CHENODEOXYCHOLIC ACID; FARNESOID X RECEPTOR; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; N ACETYLGLUCOSAMINE; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); RETINOID X RECEPTOR; SUMO PROTEIN; UNCLASSIFIED DRUG;

BILE ACID METABOLISM; BINDING AFFINITY; CHROMATIN IMMUNOPRECIPITATION; DIABETIC NEPHROPATHY; DNA BINDING; DNA RESPONSIVE ELEMENT; DNA SEQUENCE; GENE EXPRESSION REGULATION; GLUCOSE HOMEOSTASIS; GLYCOLYSIS; HUMAN; HYPERGLYCEMIA; IMMORTALIZED CELL LINE; INTRACELLULAR SIGNALING; LIPOGENESIS; LIVER METABOLISM; METABOLITE; NONALCOHOLIC FATTY LIVER; NONHUMAN; PENTOSE PHOSPHATE CYCLE; PROMOTER REGION; PROTEIN DEPHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE, FUNCTION AND VARIABILITY; SHORT SURVEY; TRANSACTIVATION; TRANSCRIPTION INITIATION;

EID: 84920162021     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2014.00230     Document Type: Short Survey

References (40)

1. Yamashita H, Takenoshita M, Sakurai M, Bruick RK, Henzel WJ, Shillinglaw W, et al. A glucose-responsive transcription factor that regulates carbohydrate metabolism in the liver. Proc Natl Acad Sci U S A (2001) 98(16):9116-21. Epub 2001/07/27. doi: 10.1073/pnas.161284298 161284298 [pii]. PubMed PMID: 11470916; PubMed Central PMCID: PMC55382.
2. Kawaguchi T, Osatomi K, Yamashita H, Kabashima T, Uyeda K. Mechanism for fatty acid "sparing" effect on glucose-induced transcription: regulation of carbohydrate-responsive element-binding protein by AMP-activated protein kinase. J Biol Chem (2002) 277(6):3829-35. Epub 2001/11/29. doi: 10.1074/jbc. M107895200 M107895200 [pii]. PubMed PMID: 11724780.
3. Dentin R, Pegorier JP, Benhamed F, Foufelle F, Ferre P, Fauveau V, et al. Hepatic glucokinase is required for the synergistic action of ChREBP and SREBP-1c on glycolytic and lipogenic gene expression. J Biol Chem (2004) 279(19):20314-26. Epub 2004/02/27. doi: 10.1074/jbc. M312475200 M312475200 [pii]. PubMed PMID: 14985368.
4. Kawaguchi T, Takenoshita M, Kabashima T, Uyeda K. Glucose and cAMP regulate the L-type pyruvate kinase gene by phosphorylation/dephosphorylation of the carbohydrate response element binding protein. Proc Natl Acad Sci U S A (2001) 98(24):13710-5. Epub 2001/11/08. doi: 10.1073/pnas.231370798 231370798 [pii]. PubMed PMID: 11698644; PubMed Central PMCID: PMC61106.
5. Bricambert J, Miranda J, Benhamed F, Girard J, Postic C, Dentin R. Salt inducible kinase 2 links transcriptional coactivator p300 phosphorylation to the prevention of ChREBP-dependent hepatic steatosis in mice. J Clin Invest (2010) 120(12):4316-31. Epub 2010/11/19. doi: 41624 [pii] 10.1172/JCI41624. PubMed PMID: 21084751; PubMed Central PMCID: PMC2993582.
6. Guinez C, Filhoulaud G, Rayah-Benhamed F, Marmier S, Dubuquoy C, Dentin R, et al. O-GlcNAcylation increases ChREBP protein content and transcriptional activity in the liver. Diabetes (2011) 60(5):1399-413. Epub 2011/04/08. doi: db10-0452 [pii] 10.2337/db10-0452. PubMed PMID: 21471514; PubMed Central PMCID: PMC3292313.
7. Ido-Kitamura Y, Sasaki T, Kobayashi M, Kim HJ, Lee YS, Kikuchi O, et al. Hepatic FoxO1 integrates glucose utilization and lipid synthesis through regulation of Chrebp O-glycosylation. PLoS One (2012) 7(10):e47231. Epub 2012/10/12. doi: 10.1371/journal.pone.0047231 PONE-D-12-18280 [pii]. PubMed PMID: 23056614; PubMed Central PMCID: PMC3466224.
8. Hart GW, Slawson C, Ramirez-Correa G, Lagerlof O. Cross talk between O GlcNAcylation and phosphorylation: roles in signaling, transcription, and chronic disease. Annu Rev Biochem (2011) 80:825-58. Epub 2011/03/12. doi: 10.1146/annurev-biochem-060608-102511. PubMed PMID: 21391816.
9. Berrabah W, Aumercier P, Gheeraert C, Dehondt H, Bouchaert E, Alexandre J, et al. Glucose sensing O-GlcNAcylation pathway regulates the nuclear bile acid receptor farnesoid X receptor (FXR). Hepatology (2014) 59(5):2022-33. Epub 2013/09/17. doi: 10.1002/hep.26710. PubMed PMID: 24037988.
10. Lefebvre P, Cariou B, Lien F, Kuipers F, Staels B. Role of bile acids and bile acid receptors in metabolic regulation. Physiol Rev (2009) 89(1):147-91. Epub 2009/01/08. doi: 89/1/147 [pii] 10.1152/physrev.00010.2008. PubMed PMID: 19126757.
11. Caron S, Huaman Samanez C, Dehondt H, Ploton M, Briand O, Lien F, et al. Farnesoid X receptor inhibits the transcriptional activity of carbohydrate response element binding protein in human hepatocytes. Mol Cell Biol (2013) 33(11):2202-11. Epub 2013/03/27. doi: MCB.01004-12 [pii] 10.1128/MCB.01004-12. PubMed PMID: 23530060; PubMed Central PMCID: PMC3648076.
12. Iizuka K, Bruick RK, Liang G, Horton JD, Uyeda K. Deficiency of carbohydrate response element-binding protein (ChREBP) reduces lipogenesis as well as glycolysis. Proc Natl Acad Sci U S A (2004) 101(19):7281-6. Epub 2004/05/01. doi: 10.1073/pnas.0401516101 0401516101 [pii]. PubMed PMID: 15118080; PubMed Central PMCID: PMC409910.
13. Herman MA, Peroni OD, Villoria J, Schon MR, Abumrad NA, Bluher M, et al. A novel ChREBP isoform in adipose tissue regulates systemic glucose metabolism. Nature (2012) 484(7394):333-8. Epub 2012/04/03. doi: nature10986 [pii] 10.1038/nature10986. PubMed PMID: 22466288; PubMed Central PMCID: PMC3341994.
14. Noordeen NA, Khera TK, Sun G, Longbottom ER, Pullen TJ, da Silva Xavier G, et al. Carbohydrate-responsive element-binding protein (ChREBP) is a negative regulator of ARNT/HIF-1beta gene expression in pancreatic islet beta-cells. Diabetes (2010) 59(1):153-60. Epub 2009/10/17. doi: db08-0868 [pii] 10.2337/db08-0868. PubMed PMID: 19833882; PubMed Central PMCID: PMC2797916.
15. Jeong YS, Kim D, Lee YS, Kim HJ, Han JY, Im SS, et al. Integrated expression profiling and genome-wide analysis of ChREBP targets reveals the dual role for ChREBP in glucose-regulated gene expression. PLoS One (2011) 6(7):e22544. Epub 2011/08/04. doi: 10.1371/journal.pone.0022544 PONE-D-10-05011 [pii]. PubMed PMID: 21811631; PubMed Central PMCID: PMC3141076.
16. Rufo C, Teran-Garcia M, Nakamura MT, Koo SH, Towle HC, Clarke SD. Involvement of a unique carbohydrate-responsive factor in the glucose regulation of rat liver fatty-acid synthase gene transcription. J Biol Chem (2001) 276(24):21969-75. Epub 2001/03/30. doi: 10.1074/jbc. M100461200 M100461200 [pii]. PubMed PMID: 11279238.
17. Ma L, Robinson LN, Towle HC. ChREBP*Mlx is the principal mediator of glucose-induced gene expression in the liver. J Biol Chem (2006) 281(39):28721-30. Epub 2006/08/04. doi: M601576200 [pii] 10.1074/jbc. M601576200. PubMed PMID: 16885160.
18. Filhoulaud G, Guilmeau S, Dentin R, Girard J, Postic C. Novel insights into ChREBP regulation and function. Trends Endocrinol Metab (2013) 24(5):257-68. Epub 2013/04/20. doi: S1043-2760(13)00015-5 [pii] 10.1016/j.tem.2013.01.003. PubMed PMID: 23597489.
19. Kabashima T, Kawaguchi T, Wadzinski BE, Uyeda K. Xylulose 5-phosphate mediates glucose-induced lipogenesis by xylulose 5-phosphate-activated protein phosphatase in rat liver. Proc Natl Acad Sci U S A (2003) 100(9):5107-12. Epub 2003/04/10. doi: 10.1073/pnas.0730817100 0730817100 [pii]. PubMed PMID: 12684532; PubMed Central PMCID: PMC154306.
20. Li MV, Chang B, Imamura M, Poungvarin N, Chan L. Glucose-dependent transcriptional regulation by an evolutionarily conserved glucose-sensing module. Diabetes (2006) 55(5):1179-89. Epub 2006/04/29. doi: 55/5/1179 [pii]. PubMed PMID: 16644671.
21. Li MV, Chen W, Poungvarin N, Imamura M, Chan L. Glucose-mediated transactivation of carbohydrate response element-binding protein requires cooperative actions from Mondo conserved regions and essential trans-acting factor 14-3-3. Mol Endocrinol (2008) 22(7):1658-72. Epub 2008/04/26. doi: me.2007-0560 [pii] 10.1210/me.2007-0560. PubMed PMID: 18436566; PubMed Central PMCID: PMC2453601.
22. McFerrin LG, Atchley WR. A novel N-terminal domain may dictate the glucose response of Mondo proteins. PLoS One (2012) 7(4):e34803. Epub 2012/04/17. doi: 10.1371/journal.pone.0034803 PONE-D-11-16001 [pii]. PubMed PMID: 22506051; PubMed Central PMCID: PMC3323566.
23. Li MV, Chen W, Harmancey RN, Nuotio-Antar AM, Imamura M, Saha P, et al. Glucose-6-phosphate mediates activation of the carbohydrate responsive binding protein (ChREBP). Biochem Biophys Res Commun (2010) 395(3):395-400. Epub 2010/04/13. doi: S0006-291X(10)00690-X [pii] 10.1016/j.bbrc.2010.04.028. PubMed PMID: 20382127; PubMed Central PMCID: PMC2874883.
24. Dentin R, Tomas-Cobos L, Foufelle F, Leopold J, Girard J, Postic C, et al. Glucose 6-phosphate, rather than xylulose 5-phosphate, is required for the activation of ChREBP in response to glucose in liver. J Hepatol (2011). Epub 2011/08/13. doi: S0168-8278(11)00613-1 [pii] 10.1016/j.jhep.2011.07.019. PubMed PMID: 21835137.
25. Ishii S, Iizuka K, Miller BC, Uyeda K. Carbohydrate response element binding protein directly promotes lipogenic enzyme gene transcription. Proc Natl Acad Sci U S A (2004) 101(44):15597-602. Epub 2004/10/22. doi: 0405238101 [pii] 10.1073/pnas.0405238101. PubMed PMID: 15496471; PubMed Central PMCID: PMC524841.
26. Iizuka K, Miller B, Uyeda K. Deficiency of carbohydrate-activated transcription factor ChREBP prevents obesity and improves plasma glucose control in leptin-deficient (ob/ob) mice. Am J Physiol Endocrinol Metab (2006) 291(2):E358-64. Epub 2006/05/18. doi: 00027.2006 [pii] 10.1152/ajpendo.00027.2006. PubMed PMID: 16705063.
27. Benhamed F, Denechaud PD, Lemoine M, Robichon C, Moldes M, Bertrand-Michel J, et al. The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans. J Clin Invest (2012) 122(6):2176-94. Epub 2012/05/02. doi: 41636 [pii] 10.1172/JCI41636. PubMed PMID: 22546860; PubMed Central PMCID: PMC3366390.
28. Duran-Sandoval D, Mautino G, Martin G, Percevault F, Barbier O, Fruchart JC, et al. Glucose regulates the expression of the farnesoid X receptor in liver. Diabetes (2004) 53(4):890-8. Epub 2004/03/30. PubMed PMID: 15047603.
29. Duran-Sandoval D, Cariou B, Percevault F, Hennuyer N, Grefhorst A, van Dijk TH, et al. The farnesoid X receptor modulates hepatic carbohydrate metabolism during the fasting-refeeding transition. J Biol Chem (2005) 280(33):29971-9. Epub 2005/05/19. doi: M501931200 [pii] 10.1074/jbc. M501931200. PubMed PMID: 15899888.
30. Cariou B, van Harmelen K, Duran-Sandoval D, van Dijk T, Grefhorst A, Bouchaert E, et al. Transient impairment of the adaptive response to fasting in FXR deficient mice. FEBS Lett (2005) 579(19):4076-80. Epub 2005/07/19. doi: S0014-5793(05)00764-7 [pii] 10.1016/j.febslet.2005.06.033. PubMed PMID: 16023103.
31. Stayrook KR, Bramlett KS, Savkur RS, Ficorilli J, Cook T, Christe ME, et al. Regulation of carbohydrate metabolism by the farnesoid X receptor. Endocrinology (2005) 146(3):984-91. Epub 2004/11/27. doi: en.2004-0965 [pii] 10.1210/en.2004-0965. PubMed PMID: 15564327.
32. Mi LZ, Devarakonda S, Harp JM, Han Q, Pellicciari R, Willson TM, et al. Structural basis for bile acid binding and activation of the nuclear receptor FXR. Mol Cell (2003) 11(4):1093-100. Epub 2003/04/30. doi: S1097276503001126 [pii]. PubMed PMID: 12718893.
33. Sakiyama H, Fujiwara N, Noguchi T, Eguchi H, Yoshihara D, Uyeda K, et al. The role of O-linked GlcNAc modification on the glucose response of ChREBP. Biochem Biophys Res Commun (2010) 402(4):784-9. Epub 2010/11/03. doi: S0006-291X(10)02002-4 [pii] 10.1016/j.bbrc.2010.10.113. PubMed PMID: 21036147.
34. Balasubramaniyan N, Luo Y, Sun AQ, Suchy FJ. SUMOylation of the farnesoid X receptor (FXR) regulates the expression of FXR target genes. J Biol Chem (2013) 288(19):13850-62. Epub 2013/04/03. doi: M112.443937 [pii] 10.1074/jbc. M112.443937. PubMed PMID: 23546875; PubMed Central PMCID: PMC3650421.
35. Ma J, Hart GW. Protein O-GlcNAcylation in diabetes and diabetic complications. Expert Rev Proteomics (2013) 10(4):365-80. Epub 2013/09/03. doi: 10.1586/14789450.2013.820536. PubMed PMID: 23992419; PubMed Central PMCID: PMC3985334.
36. Dentin R, Hedrick S, Xie J, Yates J, 3rd, Montminy M. Hepatic glucose sensing via the CREB coactivator CRTC2. Science (2008) 319(5868):1402-5. Epub 2008/03/08. doi: 319/5868/1402 [pii] 10.1126/science.1151363. PubMed PMID: 18323454.
37. Park MJ, Kim DI, Lim SK, Choi JH, Han HJ, Yoon KC, et al. High glucose induced O-GlcNAcylated carbohydrate response element-binding protein (ChREBP) mediates mesangial cell lipogenesis and fibrosis: the possible role in the development of diabetic nephropathy. J Biol Chem (2014) 289(19):13519-30. Epub 2014/03/13. doi: M113.530139 [pii] 10.1074/jbc. M113.530139. PubMed PMID: 24616092; PubMed Central PMCID: PMC4036358.
38. Zhang Y, Ge X, Heemstra LA, Chen WD, Xu J, Smith JL, et al. Loss of FXR protects against diet-induced obesity and accelerates liver carcinogenesis in ob/ob mice. Mol Endocrinol (2012) 26(2):272-80. Epub 2012/01/21. doi: me.2011-1157 [pii] 10.1210/me.2011-1157. PubMed PMID: 22261820; PubMed Central PMCID: PMC3275160.
39. Prawitt J, Caron S, Staels B. Glucose-lowering effects of intestinal bile acid sequestration through enhancement of splanchnic glucose utilization. Trends Endocrinol Metab (2014) 25(5):235-44. Epub 2014/04/16. doi: S1043-2760(14)00054-X [pii] 10.1016/j.tem.2014.03.007. PubMed PMID: 24731596.
40. Matysik S, Martin J, Bala M, Scherer M, Schaffler A, Schmitz G. Bile acid signaling after an oral glucose tolerance test. Chem Phys Lipids (2011) 164(6):525-9.